IDX:MEDS Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-8,346	-8,534	-3,570	237.06	26,631
Depreciation & Amortization	4,316	4,569	4,228	2,969	1,728
Other Operating Activities	2,555	6,195	2,495	-16,230	-14,876
Operating Cash Flow	-1,475	2,230	3,152	-13,023	13,484
Operating Cash Flow Growth	-	-29.25%	-	-	-72.30%
Capital Expenditures	-1,256	-275.84	-6,084	-17,971	-27,008
Sale of Property, Plant & Equipment	144.14	636.94	-	243.24	1
Cash Acquisitions	-	-	-3.78	-	-
Other Investing Activities	-	-	-	-	-712.5
Investing Cash Flow	-1,112	361.09	-6,088	-17,728	-27,719
Long-Term Debt Issued	3,900	-	-	-	11,200
Short-Term Debt Repaid	-	-	-	-	-2,100
Long-Term Debt Repaid	-2,582	-2,777	-2,486	-2,118	-133.69
Total Debt Repaid	-2,582	-2,777	-2,486	-2,118	-2,234
Net Debt Issued (Repaid)	1,318	-2,777	-2,486	-2,118	8,966
Issuance of Common Stock	-	-	-	36,830	-
Common Dividends Paid	-	-	-	-	-7,200
Other Financing Activities	1,816	-247.5	725	-	-
Financing Cash Flow	3,134	-3,025	-1,761	34,712	1,766
Net Cash Flow	546.94	-433.48	-4,696	3,960	-12,469
Free Cash Flow	-2,731	1,954	-2,932	-30,995	-13,524
Free Cash Flow Margin	-41.20%	30.58%	-12.90%	-82.13%	-17.84%
Free Cash Flow Per Share	-1.75	1.25	-1.88	-22.57	-10.82
Cash Interest Paid	672.71	482.4	663.42	759.2	180.42
Cash Income Tax Paid	54.07	-2,287	-	1,972	16,403
Levered Free Cash Flow	1,957	4,653	7,135	-35,144	-19,723
Unlevered Free Cash Flow	2,378	4,954	7,550	-34,670	-19,610

Source: S&P Global Market Intelligence. Standard template. Financial Sources.